HRSA-26-101: Supporting Interventions with Technical Assistance
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2026.
Health Resources and Services Administration offered grants of up to $1.5 million to nonprofits, colleges and universities, state and local governments and tribes. It expected to make one award worth $1.5 million in total. Applications closed on July 13, 2026.
From the official notice on Grants.gov, last changed June 11, 2026. Checked November 7, 2026.
- Award ceiling$1.5 million
- Total funding$1.5 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 11, 2026 |
|---|---|
| Deadline | July 13, 2026 |
| Archived by Grants.gov | October 31, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
All 11 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
Is this a realistic fit?
- Past Special Projects of National Significance awards averaged $1.2 million; this notice allows up to $1.5 million per award.
- No cost sharing or match is required.
What the grant funds
The purpose of this funding opportunity is to fund one organization to implement and evaluate tailored technical assistance (TA) to Ryan White HIV/AIDS Program (RWHAP) recipients. The purpose of this initiative is to support the uptake of interventions by providing tailored, needs-based TA to RWHAP recipients and providers to address barriers to intervention start-up, such as competing priorities and not knowing how to adapt interventions to fit their organizational structures or client populations. By providing tailored TA and a one-time funding amount to cover start-up costs, RWHAP recipients and providers will be able to address these barriers and strengthen their ability to integrate and sustain innovative HIV care models. The adoption of these interventions across the HIV health care system will improve HIV health outcomes and reduce transmission of HIV. This funding opportunity is supported by the HRSA RWHAP Part F: Special Projects of National Significance (SPNS) Program. Funding supports an implementation science approach to adapt, implement, and evaluate the implementation of HIV care innovations. It also builds upon previous and current projects to increase the uptake of disseminated interventions that have been funded by HRSA"s HIV/AIDS Bureau (HAB).The proposed initiative will identify a representative set of RWHAP recipient and/or provider sites (up to 20 sites funded as subrecipients by the recipient, divided into two (2) phases) to receive short-term, tailored implementation support and resources to jump start efforts to adapt or replicate existing interventions. The recipient will work with the sites to understand their specific needs and organizational structure to develop tailored resources and TA to adapt or replicate selected emerging, evidence-informed, and evidence-based interventions and other HIV care innovations.
Who has won Special Projects of National Significance grants before
From fiscal 2021 to 2025, Special Projects of National Significance (93.928) awarded $104 million across 85 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fenway Community Health Center, Inc. | Massachusetts | 2 | $20.1 million |
| National Alliance of State & Territorial AIDS Directors | District of Columbia | 1 | $13.9 million |
| Jsi Research & Training Institute Inc | Massachusetts | 6 | $13.3 million |
| Corporation for Supportive Housing | New York | 1 | $13.2 million |
| The Regents of the University of California, San Francisco | California | 4 | $6.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-26-101 still open?
No. It closed on July 13, 2026.
Who can apply for Supporting Interventions with Technical Assistance?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, state and local governments and tribes.
What is the deadline for Supporting Interventions with Technical Assistance?
Closed July 13, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.5 million each. About $1.5 million in total for one award.
Who has won Special Projects of National Significance grants before?
The largest recipients over five fiscal years were Fenway Community Health Center, Inc., National Alliance of State & Territorial AIDS Directors, Jsi Research & Training Institute Inc. The program made 85 awards worth $104 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)